ライフサイエンスコーパス: photodynamic

1 ew types of disinfection strategies based on photodynamic ((1)O(2)) bubble carriers.

2 ize the photoreactivity and achieve the best photodynamic action.

3 Photodynamic activation with PICELs specifically killed

4 TCP-C60 film is an interesting and versatile photodynamic active surface to eradicate bacteria.

5 derivative exhibited exceptionally effective photodynamic activity on a number of tumor cell lines (H

6 ndogenous AhR ligand FICZ displays nanomolar photodynamic activity representing a molecular mechanism

7 The excellent photodynamic activity resulted from the rigid spatial ar

8 y inducing keratinocyte cell death, and FICZ photodynamic activity was also substantiated in a murine

9 High photodynamic activity was observed for hexadeca-cationic

10 that (3)IL states of this nature are potent photodynamic agents, exhibiting the largest photocytotox

11 Cu2-XTe) nanocubes (NCs) as photothermal and photodynamic agents, leading to significant anticancer a

12 e and NIR radiate on at 4 degrees C revealed photodynamic and photothermal as mechanism of cytotoxici

13 and ultrafast experimental studies of their photodynamics and discuss the results in comparison to t

14 On the basis of photodynamics and electron transfer theory, the prevalen

15 Spectral, photophysical, photodynamic, and biological properties of compound were

16 ermore, the trimodal therapy (photothermal-, photodynamic- and chemo-therapy) with SN-NPM demonstrate

17 alue up to 0.91, lambdamax up to 750 nm) and photodynamic anticancer activity.

18 yrrole drives their photoactivity, but their photodynamics are only partially understood.

19 port here for the first time on a reversible photodynamic bulk optode sensor based on the photoswitch

20 Experiments on image-guided photodynamic cancer ablation show that the therapeutic p

21 on chlorin as a partially approved drug for photodynamic cancer therapy, the concept is universal an

22 issues, and delivery of photosensitizers for photodynamic cancer therapy.

23 ding chemo-drugs, nucleotides, peptides, and photodynamic chemicals could be simply encapsulated into

24 l bridged binaphthyl units were developed as photodynamic chiral dopants for nematic liquid crystals.

25 >S2 transition will introduce a more complex photodynamics compared with S0-->S1 transition.

26 ated micelles exhibited significant in vitro photodynamic cytotoxicity.

27 ng intravenous PMIL administration, triggers photodynamic damage of tumour cells and microvessels, an

28 Failure to assemble such complexes provoked photodynamic damage through the generation of singlet ox

29 infrared laser irradiation induced vascular photodynamic damage, resulting in enhanced liposomal dox

30 nology such as optical coherence tomography, photodynamic diagnosis and narrow band imaging might be

31 Molecular targets for photodynamic diagnosis are currently under investigation

32 e supports macroscopic applications, such as photodynamic diagnosis or narrow band imaging, and their

33 in urologic surgery were reviewed, including photodynamic diagnosis, near infrared fluorescence imagi

34 alization and patterning strategy based on a photodynamic disulfide exchange reaction is demonstrated

35 s for CSCR are still evolving, in particular photodynamic dynamic therapy using lower doses and reduc

36 ncreased the cellular uptake by >60% and the photodynamic effect of hydrophobic porphyrins in vitro c

37 r-soluble conjugates were screened for their photodynamic efficacy against several cancer cell lines

38 llular uptake, subcellular distribution, and photodynamic efficacy.

39 Moreover, high photodynamic efficiency was demonstrated at doses of 150

40 ity on GABA(A) receptors at baseline induced photodynamic enhancement of GABA(A) receptors.

41 We emphasize the unique feature of photodynamic equilibria, in which population of the stat

42 Here we use photodynamic imaging, mass spectrometry, parasite gene d

43 of photodynamic therapy (PDT) and microbial photodynamic inactivation (PDI) in clinical applications

44 egular cells was successfully tested via the photodynamic inactivation of a ROS stressed Gram negativ

45 Photodynamic inactivation of bacteria (PIB) uses light a

46 Photodynamic inactivation of microbial cells using light

47 n HaCaT and primary epidermal keratinocytes, photodynamic induction of apoptosis was elicited by the

48 thout light illumination yet highly enhanced photodynamic inhibition efficacy against Hela cells unde

49 and were consequently the primary targets of photodynamic injury, resulting in predominantly necrotic

50 tion and hence signaling, but the underlying photodynamic mechanisms are not known.

51 , public awareness regarding the presence of photodynamic naphthodianthrones fagopyrins that can caus

52 of hydrogen bonds significantly altered the photodynamics of guanine.

53 ing sequential intermediates for the initial photodynamics of isomerization.

54 azol-5(4H)-one (OHBI) to model the gas-phase photodynamics of such 2-hydroxy-substituted chromophores

55 The primary ultrafast Z-to-E isomerization photodynamics of the phytochrome-related cyanobacterioch

56 ral photochemical properties and studied the photodynamics of two model systems in more detail, obser

57 t preclinical evidence that a subtumoricidal photodynamic priming (PDP) strategy can relieve drug del

58 Such photodynamic production of singlet oxygen is thought to

59 ulted in an adenylate cyclase with a sixfold photodynamic range.

60 SELP was prepared, modified, and studied for photodynamic responses.

61 We describe here the use of a photodynamic selection technique to generate a populatio

62 e has allowed identifying discrete molecular photodynamic steps, action of molecular motors, protein

63 This photodynamic strategy has the advantage of exploiting ho

64 In vitro photodynamic studies were conducted on human breast canc

65 ar dichroism, fluorescence spectroscopy, and photodynamic techniques.

66 nowhiskers (TP) as effective bio-imaging and photodynamic therapeutic (PDT) agent for RA theranostics

67 sed porphyrin (NCP) was synthesized, and the photodynamic therapeutic (PDT) application was investiga

68 hese visible photons have been combined with photodynamic therapeutic agents preclinically for increa

69 e design guideline for enhancing traditional photodynamic therapeutic efficacy integrated with a cont

70 diagnostics and analytics, photothermal and photodynamic therapies, and delivery of target molecules

71 echanism for PIT as compared to conventional photodynamic therapies.

72 alfa-2b (0% vs 1%), cryotherapy (0% vs 3%), photodynamic therapy (0% vs 1%), excisional biopsy and c

73 randomly assigned (1:1) to vascular-targeted photodynamic therapy (4 mg/kg padeliporfin intravenously

74 or 0.5 mg), sham injections plus verteporfin photodynamic therapy (ANCHOR), or sham injections alone

75 ts of repeated applications of antimicrobial photodynamic therapy (aPDT) adjunctive to scaling and ro

76 im of this study is to compare antimicrobial photodynamic therapy (aPDT) as an adjunctive therapy to

77 Antimicrobial photodynamic therapy (aPDT) as an adjunctive treatment i

78 Antimicrobial photodynamic therapy (aPDT) is an emerging treatment for

79 a promising photosensitizer in antimicrobial photodynamic therapy (aPDT).

80 low-intensity laser (LIL); 2) antimicrobial photodynamic therapy (aPDT); or 3) toluidine blue O (TBO

81 notherapy or combination IVB and verteporfin photodynamic therapy (IVB/PDT).

82 ng for subsequent surgical excision (n = 3), photodynamic therapy (n = 1), or cryotherapy (n = 1) for

83 ffect compared with reovirus monotherapy and photodynamic therapy (p=0.042) with 100% cell death obse

84 otic lesions followed by aminolevulinic acid photodynamic therapy (PDT) 1 to 2 weeks later.

85 ing pigment (methylene blue - MB) to mediate photodynamic therapy (PDT) against Streptococcus mutans

86 ypyridyl complexes show great promise as new photodynamic therapy (PDT) agents.

87 rties were investigated for use as potential photodynamic therapy (PDT) agents.

88 e recently contributed to the progression of photodynamic therapy (PDT) and microbial photodynamic in

89 cy ablation (RFA), but other data pertain to photodynamic therapy (PDT) and other modalities.

90 , presumably through the combined effects of photodynamic therapy (PDT) and released chemotherapy dru

91 Cationic antimicrobial peptides (CAMPs) and photodynamic therapy (PDT) are attractive tools to comba

92 inical experiments addressing the effects of photodynamic therapy (PDT) as an adjunct to conventional

93 This study investigates the effect of photodynamic therapy (PDT) as monotherapy during support

94 opportunities of NP imaging and therapy on a photodynamic therapy (PDT) based NP system that has been

95 Photodynamic therapy (PDT) can destroy local tumors and

96 we have found that addition of erlotinib to photodynamic therapy (PDT) can improve treatment respons

97 The efficacy of photodynamic therapy (PDT) depends upon the delivery of

98 Photodynamic therapy (PDT) efficacy is limited by the ve

99 neration and exhibits significantly enhanced photodynamic therapy (PDT) efficacy on two colon cancer

100 Moreover, it could be shown that photodynamic therapy (PDT) elevates antitumor immune res

101 vitro, including both chemotherapy drugs and photodynamic therapy (PDT) for ovarian cancer.

102 Photodynamic therapy (PDT) has been applied in cancer tr

103 Photodynamic therapy (PDT) has been successfully used to

104 In recent years photodynamic therapy (PDT) has received widespread atten

105 for their potential as photosensitizers for photodynamic therapy (PDT) in P-glycoprotein (P-gp) expr

106 herapy in ancient texts and the discovery of photodynamic therapy (PDT) in the early 1900s, the landm

107 Photodynamic therapy (PDT) involves the intravenous admi

108 Photodynamic therapy (PDT) is a clinically approved anti

109 Photodynamic therapy (PDT) is a light-based treatment mo

110 Photodynamic therapy (PDT) is a new strategy for treatin

111 Photodynamic therapy (PDT) is a promising approach to tr

112 Photodynamic therapy (PDT) is a promising treatment stra

113 Photodynamic therapy (PDT) is a rapidly developing appro

114 Photodynamic therapy (PDT) is a technique developed to t

115 Photodynamic therapy (PDT) is an alternative treatment f

116 Photodynamic therapy (PDT) is an effective and cosmetica

117 Photodynamic therapy (PDT) is an effective anticancer pr

118 Photodynamic therapy (PDT) is an efficacious treatment f

119 Photodynamic therapy (PDT) is an important cancer treatm

120 Photodynamic therapy (PDT) is generally based on the gen

121 Photodynamic therapy (PDT) is used extensively to treat

122 Photodynamic therapy (PDT) is widely used to treat diver

123 Photodynamic therapy (PDT) is widely used to treat non-m

124 With the knowledge that the dominant photodynamic therapy (PDT) mechanism of 1a (WST09) switc

125 ial of this conjugate as photosensitizer for photodynamic therapy (PDT) of cancers overexpressing the

126 Singlet oxygen sensitized photodynamic therapy (PDT) relies on the concentration o

127 Photodynamic therapy (PDT) stands to benefit from improv

128 Although photodynamic therapy (PDT) takes advantage of the spatia

129 treatment, it allowed delivery of selective photodynamic therapy (PDT) to the cancerous tissues, wit

130 Furthermore, immunogenic ZnP@pyro photodynamic therapy (PDT) treatment sensitizes tumors t

131 e entrapped agents that harnesses sub-lethal photodynamic therapy (PDT) using a photosensitiser that

132 3 months, additional treatment with laser or photodynamic therapy (PDT) was considered if any fluores

133 chanisms how the efficacy of photofrin based photodynamic therapy (PDT) was enhanced by miR-99a trans

134 racellular localization and cell response to photodynamic therapy (PDT) were analyzed in MCF10A norma

135 integration of fluorescence imaging (FL) and photodynamic therapy (PDT) with positron emission tomogr

136 Photodynamic therapy (PDT) with protoporphyrin IX (PpIX)

137 nalysis evaluated patients who had undergone photodynamic therapy (PDT) within the preceding year (N

138 nstrate that benzoporphyrin derivative-based photodynamic therapy (PDT), a photochemical cytotoxic mo

139 Photodynamic therapy (PDT), a photochemistry-based cytot

140 f cancer and dermatological diseases through photodynamic therapy (PDT), and advanced materials for e

141 In photodynamic therapy (PDT), cells are impregnated with a

142 additional limitations of porphyrin-mediated photodynamic therapy (PDT), including low depths of tiss

143 ent procedures, such as laser irradiation or photodynamic therapy (PDT), may provide some additional

144 each clinical treatment tool (chemotherapy, photodynamic therapy (PDT), radiotherapy (RT)) by contro

145 In the case of photodynamic therapy (PDT), two-photon absorption combin

146 ptake of photosensitizers by cancer cells in photodynamic therapy (PDT), we designed a smart plasma m

147 Photodynamic therapy (PDT), wherein light sensitive non-

148 PCI is founded upon the principle of photodynamic therapy (PDT), which uses light to activate

149 ing because (1)O2 plays an important role in photodynamic therapy (PDT).

150 or as the shell for potential application in photodynamic therapy (PDT).

151 erapy (PTT), and light to singlet oxygen for photodynamic therapy (PDT).

152 n investigated as photosensitizers (PSs) for photodynamic therapy (PDT).

153 at are illuminated, and this is the basis of photodynamic therapy (PDT).

154 a photosensitizer that acts as an agent for photodynamic therapy (PDT).

155 aptive immunity following treatments such as photodynamic therapy (PDT).

156 tment protocols, including dental lasers and photodynamic therapy (PDT).

157 esized and characterized as novel agents for photodynamic therapy (PDT).

158 al candidates for use as photosensitizers in photodynamic therapy (PDT).

159 ent protoporphyrin IX (PPIX) accumulation in photodynamic therapy (PDT).

160 et oxygen ((1) O2 ) is of great interest for photodynamic therapy (PDT).

161 ce lifetime microscopy (2PLM) and two-photon photodynamic therapy (PDT).

162 ture-activity relationships for their use in photodynamic therapy (PDT).

163 CP@pyrolipid) for effective chemotherapy and photodynamic therapy (PDT).

164 MRI contrasting agents, and sensitizers for photodynamic therapy (PDT); and more recently as models

165 (MARINA), or were randomized to verteporfin photodynamic therapy (PDT; n=143), 0.3-mg ranibizumab mo

166 vitreal anti-VEGF injection; (3) verteporfin photodynamic therapy (vPDT); or (4) laser photocoagulati

167 xamine the hypothesis that vascular-targeted photodynamic therapy (VTP) with WST11 and clinically rel

168 ine) and their applications in X-ray-induced photodynamic therapy (X-PDT) of colon cancer.

169 therapy and the other half treated with AWL photodynamic therapy 1 week apart and randomly allocated

170 bial and antiviral agents, anticancer drugs, photodynamic therapy agents, radiotherapy agents and bio

171 y assigned 206 patients to vascular-targeted photodynamic therapy and 207 patients to active surveill

172 e findings may help to alleviate pain during photodynamic therapy and also allow for disease modifica

173 mes were after vs before the introduction of photodynamic therapy and anti-vascular endothelial growt

174 Combination therapy incorporating photodynamic therapy and antivascular endothelial growth

175 ffectiveness and adverse effects of daylight photodynamic therapy and artificial white light (AWL) LE

176 e optogenetic control over neurons, targeted photodynamic therapy and deep tissue imaging.

177 ies based on oxygen free radicals, including photodynamic therapy and radiotherapy, have emerged as p

178 ad half of their scalp treated with daylight photodynamic therapy and the other half treated with AWL

179 Of the new non-invasive treatments, only photodynamic therapy and topical imiquimod have become e

180 mus) and the most promising absorptivity for photodynamic therapy application, was tested as efficien

181 contrast generation settings, as well as its photodynamic therapy application.

182 Near-IR absorption, desired for potential photodynamic therapy applications, was not pursuable for

183 Oncolytic viral therapy and photodynamic therapy are potential therapies for inopera

184 ession in cancer cells and susceptibility to photodynamic therapy based on their increased ability to

185 atoses (AKs) is as effective as conventional photodynamic therapy but has the advantage of being almo

186 Photodynamic therapy can be an effective alternative for

187 Photodynamic therapy combining nanotechnology has shown

188 Here we demonstrate a photodynamic therapy construct that integrates both a cy

189 -VEGF therapy increased from 60.3% to 72.7%, photodynamic therapy decreased from 12.8% to 5.3%, and t

190 Rose bengal- and riboflavin-mediated photodynamic therapy demonstrated complete growth inhibi

191 imaging and synergetic photothermal therapy/photodynamic therapy derived from the porphyrin-like moi

192 osensitizers into nanostructures can improve photodynamic therapy efficacy and the safety profile of

193 re to sunlight and other patients undergoing photodynamic therapy experience similar pain, which can

194 e variety of potential applications, such as photodynamic therapy for accelerated drug screening, mag

195 therapy and artificial white light (AWL) LED photodynamic therapy for the treatment of AKs on the for

196 eporfin (VP), a light-activated drug used in photodynamic therapy for the treatment of choroidal neov

197 was 58 (28%) of 206 in the vascular-targeted photodynamic therapy group compared with 120 (58%) of 20

198 101 (49%) men in the vascular-targeted photodynamic therapy group had a negative prostate biops

199 tatitis (three [2%] in the vascular-targeted photodynamic therapy group vs one [<1%] in the active su

200 rious adverse event in the vascular-targeted photodynamic therapy group was retention of urine (15 pa

201 Photodynamic therapy has a 14%better chance of complete

202 Methyl aminolevulinate photodynamic therapy has been effective in 1 case but in

203 The non-invasive photodynamic therapy has been limited to treat superfici

204 The Microneedle Photodynamic Therapy II (MNPDT-II) study was a randomize

205 Photodynamic therapy in combination with antivascular en

206 lar endothelial growth factor or verteporfin photodynamic therapy in combination with systemic chemot

207 d treatment with the possibility of combined photodynamic therapy in refractory cases.

208 TERPRETATION: Padeliporfin vascular-targeted photodynamic therapy is a safe, effective treatment for

209 Padeliporfin vascular-targeted photodynamic therapy is a safe, effective treatment for

210 Photodynamic therapy is the combination of non-toxic pho

211 Photodynamic therapy may be an effective therapeutic opt

212 bles can act as ideal miniature reactors for photodynamic therapy of cancer cells.

213 frared light, which has great implication in photodynamic therapy of deep-tissue cancers.

214 guided sensitizer delivery for the potential photodynamic therapy of hypoxic structures requiring cyt

215 omedical applications is exemplified here as photodynamic therapy of malignancies.

216 croneedles could be a promising approach for photodynamic therapy of skin tumors.

217 zed and investigated as photosensitizers for photodynamic therapy of tumors.

218 bined with protoporphyrin IX (PpIX)-mediated photodynamic therapy on a variety of human pancreatic ca

219 gnosed as having exudative ARMD who received photodynamic therapy or anti-VEGF therapy compared with

220 atform for the high-throughput assessment of photodynamic therapy photosensitizer (PDT) efficacy on E

221 Photodynamic therapy regimens, which use light-activated

222 Two eyes received photodynamic therapy rescue during subsequent follow-up

223 Reovirus with PpIX-mediated photodynamic therapy resulted in a significantly increas

224 Photodynamic therapy that uses photosensitizers which on

225 s oncolytic viral therapy with PpIX-mediated photodynamic therapy to treat pancreatic cancer.

226 Photodynamic therapy using an AWL source was as effectiv

227 Photodynamic therapy using porfimer (P-PDT) improves pal

228 Daylight photodynamic therapy using topical methyl 5-aminolevulin

229 Photodynamic therapy using verteporfin at a dose of 6 mg

230 The effect of adding reovirus after photodynamic therapy was also assessed.

231 Photodynamic therapy was associated with improved VA and

232 Next, the potential of SCPNs for photodynamic therapy was evaluated.

233 Their photosensitizing potential for photodynamic therapy was investigated in an in vitro mod

234 The potential of PPIX for photodynamic therapy was tested in vivo.

235 Vascular-targeted photodynamic therapy was well tolerated.

236 ects of reovirus combined with PpIX-mediated photodynamic therapy were analysed in methylthiazoltetra

237 Anti-VEGF agents and photodynamic therapy were the only interventions identif

238 in rare diseases, such as porphyrias, and in photodynamic therapy where short-term toxicity is intend

239 itization represents a promising approach in photodynamic therapy where the design of the active phot

240 photothermal therapy and porphyrin-mediated photodynamic therapy which results in complete tumor eli

241 Photodynamic therapy with microneedle pretreatment at a

242 Photodynamic therapy with the construct was successful i

243 Vascular-targeted photodynamic therapy, a novel tissue-preserving treatmen

244 ing oxidant production by transition metals, photodynamic therapy, activated macrophages, and platele

245 emonstrates a highly promising new agent for photodynamic therapy, and attracts attention to photosta

246 peutics and biologics, chemotherapeutics and photodynamic therapy, and chemotherapeutics and radiothe

247 re interesting for model enzymes, catalysis, photodynamic therapy, and electron transfer.

248 al in coordination chemistry, anion sensing, photodynamic therapy, and optoelectronics.

249 ch terms solar keratosis, actinic keratosis, photodynamic therapy, and photochemotherapy.

250 cations, including therapeutic (photothermal/photodynamic therapy, chemotherapy and synergistic thera

251 as photosynthesis, vision, photolithography, photodynamic therapy, etc., is yet to become a common to

252 for phototherapeutic interventions, such as photodynamic therapy, has transformed medicine and biolo

253 Daylight photodynamic therapy, however, requires dry and warm wea

254 Photodynamic therapy, in which malignant tissue is kille

255 interventions (argon laser photocoagulation, photodynamic therapy, intravitreal corticosteroids, and

256 iolet and visible light, and also to develop photodynamic therapy, it is important to resolve the mec

257 Photodynamic therapy, mediated by exogenously administer

258 Case studies of photodynamic therapy, oral pentoxyphylline and hyperbari

259 addition, light activation has potential in photodynamic therapy, photothermal therapy, radiotherapy

260 , which is used as an antimicrobial agent in photodynamic therapy, potentiates tellurite toxicity.

261 gated as cytotoxic agents and inhibitors, in photodynamic therapy, radiation therapy, drug/gene deliv

262 rapies were identified: electrochemotherapy, photodynamic therapy, radiotherapy, intralesional therap

263 re either ineligible for or nonresponsive to photodynamic therapy, the standard treatment at the time

264 omy, cryotherapy, laser photocoagulation, or photodynamic therapy, were excluded from the analysis.

265 Verteporfin (VP) was first used in Photodynamic therapy, where a non-thermal laser light (6

266 mour cells with low or no PTEN expression to photodynamic therapy, which is based on the ability of p

267 l of oral infections, including their use in photodynamic therapy, will be discussed in this review.

268 Antibody-based photodynamic therapy-photoimmunotherapy (PIT)-is an idea

269 Photodynamic therapy-related complications included intr

270 as effective and well-tolerated as daylight photodynamic therapy.

271 VEGF) interventions, dietary supplements, or photodynamic therapy.

272 econtouring, and antitumor and antimicrobial photodynamic therapy.

273 sensitizers for photocontrolled-delivery and photodynamic therapy.

274 erved between added reovirus before or after photodynamic therapy.

275 a history of choroidal neovascularization or photodynamic therapy.

276 orescence probes, as well as sensitizers for photodynamic therapy.

277 al wastewater treatment, photochemistry, and photodynamic therapy.

278 oninvasive optical imaging, optogenetics and photodynamic therapy.

279 ch as imaging combined with drug delivery or photodynamic therapy.

280 r photocoagulation, CyberKnife radiation, or photodynamic therapy.

281 therapy, hyper- or hypothermic therapy, and photodynamic therapy.

282 s, which makes them potentially suitable for photodynamic therapy.

283 s in photothermal therapy, chemotherapy, and photodynamic therapy.

284 lation of photosensitizer drugs in tumors in photodynamic therapy.

285 for light-triggered biological reactions and photodynamic therapy.

286 oxaliplatin chemotherapy, radiotherapy, and photodynamic therapy.

287 n of disease and any previous treatment with photodynamic therapy.

288 ential as photosensitizers for metal-organic photodynamic therapy.

289 topical or injection interferon alfa-2b, and photodynamic therapy.

290 adverse effects, and cost, limit the use of photodynamic therapy.

291 itization, a limitation often encountered in photodynamic therapy.

292 itor, sensitizes xenotransplanted tumours to photodynamic therapy.

293 role of singlet oxygen and (1)O2 carriers in photodynamic therapy.

294 on with Photodynamic Therapy; Verteporfin in Photodynamic Therapy; VEGF Inhibition Study in Ocular Ne

295 ent of Age-Related Macular Degeneration with Photodynamic Therapy; Verteporfin in Photodynamic Therap

296 The photodynamic treatment of 3T3, HeLa, SK-MEL-28, and HCT

297 The subcellular changes upon photodynamic treatment of the HeLa cells indicated that

298 tSerpin1 repressed cell death, only under AO photodynamic treatment.

299 eting and multi-drug strategy, chemo-/radio-/photodynamic-/ultrasound-/thermo-combined multi-modal th

300 Global fold, stability, and photodynamics were analyzed in detergent by CD, stationa